1
|
Jamison DT, Summers LH, Chang AY, Karlsson O, Mao W, Norheim OF, Ogbuoji O, Schäferhoff M, Watkins D, Adeyi O, Alleyne G, Alwan A, Anand S, Belachew R, Berkley SF, Bertozzi SM, Bolongaita S, Bundy D, Bustreo F, Castro MC, Chen S, Fan VY, Fawole A, Feachem R, Gebremedhin L, Ghosh J, Goldie SJ, Gonzalez-Pier E, Guo Y, Gupta S, Jha P, Knaul FM, Kruk ME, Kurowski C, Liu GG, Makimoto S, Mataria A, Nugent R, Oshitani H, Pablos-Mendez A, Peto R, Sekhri Feachem N, Reddy S, Salti N, Saxenian H, Seyi-Olajide J, Soucat A, Verguet S, Zimmerman A, Yamey G. Global health 2050: the path to halving premature death by mid-century. Lancet 2024; 404:1561-1614. [PMID: 39419055 DOI: 10.1016/s0140-6736(24)01439-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/09/2024] [Revised: 07/09/2024] [Accepted: 07/09/2024] [Indexed: 10/19/2024]
Affiliation(s)
- Dean T Jamison
- Institute for Global Health Sciences, University of California, San Francisco, San Francisco, CA, USA
| | - Lawrence H Summers
- Mossavar-Rahmani Center for Business and Government, John F Kennedy School of Government, Harvard University, Cambridge, MA, USA
| | - Angela Y Chang
- Danish Centre for Health Economics, University of Southern Denmark, Odense, Denmark
| | - Omar Karlsson
- Duke Global Health Institute, Duke University, Durham, NC, USA
| | - Wenhui Mao
- Duke Global Health Institute, Duke University, Durham, NC, USA
| | - Ole F Norheim
- Bergen Centre for Ethics and Priority Setting in Health, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway
| | - Osondu Ogbuoji
- Duke Global Health Institute, Duke University, Durham, NC, USA
| | | | - David Watkins
- Department of Global Health, University of Washington, Seattle, WA, USA
| | | | | | - Ala Alwan
- WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt
| | - Shuchi Anand
- Division of Nephrology, Stanford University, Stanford, CA, USA
| | | | - Seth F Berkley
- Pandemic Center, School of Public Health, Brown University, Providence, RI, USA
| | - Stefano M Bertozzi
- School of Public Health, University of California, Berkeley, Berkeley, CA, USA
| | - Sarah Bolongaita
- Bergen Centre for Ethics and Priority Setting in Health, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway
| | - Donald Bundy
- Department of Population Health, London School of Hygiene & Tropical Medicine, London, England, UK
| | - Flavia Bustreo
- Partnership for Maternal, Newborn and Child Health, Geneva, Switzerland
| | - Marcia C Castro
- Department of Global Health and Population, Harvard TH Chan School of Public Health, Boston, MA, USA
| | - Simiao Chen
- Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany
| | | | | | - Richard Feachem
- Institute for Global Health Sciences, University of California, San Francisco, San Francisco, CA, USA
| | - Lia Gebremedhin
- Harvard Ministerial Leadership Program, Division of Policy Translation and Leadership Development, Harvard TH Chan School of Public Health, Harvard University, Boston, MA, USA
| | - Jayati Ghosh
- Department of Economics, College of Social & Behavioral Sciences, University of Massachusetts Amherst, Amherst, MA, USA
| | - Sue J Goldie
- Department of Health Policy and Management, Harvard TH Chan School of Public Health, Harvard University, Boston, MA, USA
| | | | - Yan Guo
- Institute for Global Health and Development, School of Public Health, Peking University, Beijing, China
| | | | - Prabhat Jha
- Unity Health Toronto, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
| | - Felicia Marie Knaul
- Institute for Advanced Study of the Americas, Leonard M Miller School of Medicine, University of Miami, Miami, FL, USA
| | - Margaret E Kruk
- Department of Global Health and Population, Harvard TH Chan School of Public Health, Boston, MA, USA
| | | | - Gordon G Liu
- Institute for Global Health and Development, School of Public Health, Peking University, Beijing, China
| | - Saeda Makimoto
- Ogata Sadako Research Institute for Peace and Development, Japan International Cooperation Agency, Tokyo, Japan
| | - Awad Mataria
- WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt
| | - Rachel Nugent
- Department of Global Health, University of Washington, Seattle, WA, USA
| | - Hitoshi Oshitani
- Department of Virology, Graduate School of Medicine, Tohoku University, Sendai, Japan
| | - Ariel Pablos-Mendez
- Division of General Internal Medicine, Columbia University Irving Medical Center, New York, NY, USA
| | - Richard Peto
- Nuffield Department of Population Health, Oxford University, Oxford, UK
| | - Neelam Sekhri Feachem
- Center for Global Health Diplomacy, Delivery, and Economics, University of California, San Francisco, San Francisco, CA, USA
| | | | - Nisreen Salti
- Department of Economics, American University of Beirut, Beirut, Lebanon
| | | | | | - Agnes Soucat
- Agence Française de Développement, Paris, France
| | - Stéphane Verguet
- Department of Global Health and Population, Harvard TH Chan School of Public Health, Boston, MA, USA
| | | | - Gavin Yamey
- Duke Global Health Institute, Duke University, Durham, NC, USA.
| |
Collapse
|
2
|
Xu Y, Feng H, Zhang L, Li Y, Chi F, Ren L. Prevalence and clinical correlates of hyperhomocysteinemia in Chinese urban population with hypertension. Front Endocrinol (Lausanne) 2024; 15:1369997. [PMID: 38444590 PMCID: PMC10912325 DOI: 10.3389/fendo.2024.1369997] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/13/2024] [Accepted: 02/05/2024] [Indexed: 03/07/2024] Open
Abstract
Context The coexistence of hypertension and elevated homocysteine (Hcy) levels has a mutually reinforcing impact on the susceptibility to cardio-cerebrovascular disease. Objective The aim was to assess the prevalence, clinical correlation, and demographic characteristics of hyperhomocysteinemia (HHcy) within the Chinese urban population with hypertension. Methods A cohort of 473 individuals with hypertension were selected from four communities in Shenzhen, China. Demographic attributes, clinical profiles, and lifestyle behaviors were gathered and compared between individuals with and without HHcy. A logistic regression model was employed to examine potential factors associated with the prevalence of HHcy. Correlation between Hcy levels and clinical characteristics was assessed through multiple linear regression analysis. Results The prevalence of HHcy in the population with hypertension was 31.3%. In comparison to individuals without HHcy, those with HHcy exhibited a higher proportion of males, a higher prevalence of smoking and alcohol consumption, and a higher proportion of cases with the homozygous (TT) genotype at the MTHFR C677T polymorphism. Moreover, individuals with HHcy had lower levels of folic acid (FA), and lower fruit and vitamin B12 intake. Furthermore, the risk factors for HHcy were male (B = 1.430, OR = 4.179) and MTHFR (TT) (B = 1.086, OR = 2.961). In addition, the multiple linear regression analysis revealed a significant association between Hcy levels and gender (B = -2.784, P = 0.004), MTHFR genotypes (B = 1.410, P = 0.005), and FA levels (B = -0.136, P = 0.030). Conclusion The high prevalence of HHcy among hypertensive patients in this Chinese urban population underscores the necessity for interventions targeting modifiable risk factors such as dietary choices and lifestyle practices.
Collapse
Affiliation(s)
| | | | | | | | | | - Lijie Ren
- Department of Neurology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital, Shenzhen, China
| |
Collapse
|
3
|
Wang X, Dai M, Xu J. Association of living alone and living alone time with hypertension among Chinese men aged 80 years and older: a cohort study. Front Public Health 2024; 11:1274955. [PMID: 38249394 PMCID: PMC10796616 DOI: 10.3389/fpubh.2023.1274955] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2023] [Accepted: 12/14/2023] [Indexed: 01/23/2024] Open
Abstract
Objective There is little evidence of the influence of living alone on hypertension risk among men 80 years or older. Additionally, the influence of living alone duration on hypertension risk lacks thorough investigation. Hence, this cohort study examines living alone and its duration's link to hypertension risk in this specific group. Methods We included 2009 older men aged ≥80 years without hypertension from the Chinese Longitudinal Healthy Longevity Survey in the 2008 wave. Follow-up was conducted in the 2011 wave. Multivariable Cox proportional hazards models estimated hazard ratios (HRs) and 95% confidence intervals (CIs) to assess hypertension risk related to living alone and living alone time. Results We included 2,009 older men, with a mean age of 90.7 years (standard deviation: 6.8). Over a median follow-up of 2.9 (1.3-3.0) years, 573 participants (28.5%) developed hypertension. Living alone was significantly associated with a higher hypertension risk than living with family (HR: 1.42; 95% CI 1.11-1.80). When compared to living with family, the hypertension risk was increased in the first quartile of living alone time (0-6.1 years) (HR: 1.76; 95% CI 1.16-2.66), the second quartile (6.1-10.6 years) (HR: 1.56; 95% CI 1.07-2.29), and the third quartile (10.6-19.3 years) (HR: 1.66; 95% CI 1.08-2.55). Surprisingly, no significant association was found in the fourth quartile (≥19.3 years) with hypertension risk. Stratified and Interaction analyses indicated no significant interaction effects between subgroups. Sensitivity analyses yielded consistent results. Conclusion Living alone was independently associated with an increased risk of hypertension in older men. The highest risk was found in those with the least time alone. These findings imply that social isolation and lack of companionship could be pivotal in hypertension development. Furthermore, the study highlights the need to consider living alone duration when assessing its impact on health outcomes.
Collapse
Affiliation(s)
- Xiang Wang
- Department of Cardiology, The Second Affiliated Hospital of Nanchang University, Nanchang, China
- Department of Cardiology, Jiujiang First People’s Hospital, Jiujiang, China
| | - Miao Dai
- Department of Geriatrics, Jiujiang First People’s Hospital, Jiujiang, China
| | - Jingsong Xu
- Department of Cardiology, The Second Affiliated Hospital of Nanchang University, Nanchang, China
| |
Collapse
|